Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
PFIZER stock was riding high in June 2015, up 128 per cent in five years, making it the second most valuable US drugmaker. Nine out of 10 Wall Street research analysts recommended that investors hold it in their portfolio, if not buy more.
That same month, however, a different type of...